Try our Advanced Search for more refined results

June 22, 2012

In re: Fosamax Products

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 30, 2014

    3rd Circ. Shuts Down Generic Fosamax Appeal

    The Third Circuit on Wednesday upheld a lower court ruling that generic manufacturers of equivalents of the bone drug Fosamax could not be held liable for injuries supposedly incurred by drug users, concluding that the state-law claims asserted in the suit were preempted by federal law.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login